Heart Failure Therapeutics Market to Grow through 2025, According to New Report by GlobalData Recently Uploaded at MarketPublishers.com

16 Aug 2016 • by Natalie Aster

LONDON – In the past year, total sales of heart failure (HF) therapeutics across the 7 major markets (including Japan, the US and 5EU) were estimated at around USD 3.2 billion. This figure is predicted to increase in the years to come, registering a 13.5% CAGR. By 2025, total heart failure therapeutics sales across 7MM are likely to touch USD 11.5 billion.

Meantime, the chronic heart failure therapeutics market across 7MM is expected to increase from USD 3.1 billion in the previous year up to USD 10.1 billion by 2025, posting a CAGR of 12.7%. In 2015, the US dominated the chronic heart failure therapies market, accounting for a share of over 60% of total sales. The uptake of Novartis’ Entresto is anticipated to perform as a strong driver of the chronic heart failure and also total heart failure markets in the 7MM; in 2022 it will likely reach peak sales worth of USD 5.9 billion.

The acute heart failure therapeutics market is expected to grow from USD 188.1 million in the past year to around USD 1.5 billion in 2025, registering a 23% CAGR through 2025. In 2015, Japan held an 86% share of the acute heart failure therapeutics market. However, through 2025 the US will likely take over as the market leader with a share of nearly 68.7%.

Cutting-edge research publication “PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025” prepared by GlobalData gives a granular analysis of the world’s market for heart failure therapeutics, covering both chronic and acute sectors. It contains important details on etiology, pathophysiology, epidemiology, diagnosis, symptoms and treatment options of heart failure. The report includes info on heart failure therapeutics market revenues, explores treatment usage patterns, discloses annual costs of therapies, identifies the existing unmet needs, features the competitive scenario, contains a detailed pipeline analysis, examines the key factors shaping the market development and also presents market forecasts through 2025.

More reports by this publisher can be found in the GlobalData’s catalogue.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com